Beyond Maximum Grade: Modernising the Assessment and Reporting of Adverse Events in Haematological Malignancies

An international panel of healthcare professionals, regulators, and patient advocates reviewed the current state of side-effect assessment in the treatment of hematologic malignancies and identified potential solutions to current hurdles in optimizing care of these patients.

Lancet Haematology